2 05, 2019 Paola Bordi et al., From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC Diatech Pharmacogenetics2019-05-02T09:45:38+02:00 Mehr erfahren